Dow Up 0.36% Nasdaq Up 0.12%

Celldex Therapeutics, Inc. (CLDX)

-NasdaqGS
14.31 Down 0.80(5.29%) Aug 21, 4:00PM EDT
|After Hours : 14.31 Down 0.00 (0.02%) Aug 21, 4:56PM EDT
Prev Close:15.11
Open:15.20
Bid:14.00 x 500
Ask:15.00 x 300
1y Target Est:36.50
Beta:3.17
Earnings Date:Nov 6 - Nov 10 (Est.)
Day's Range:14.08 - 15.23
52wk Range:10.76 - 38.84
Volume:3,683,871
Avg Vol (3m):2,142,950
Market Cap:1.28B
P/E (ttm):N/A
EPS (ttm):-1.13
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CLDXDown 5.29%1.28B
DNDNDown 0.37%209.05M
LLYUp 0.03%66.48B
RHHBYDown 0.02%247.61B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):517.98
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.31
Quarterly EPS Est (Sep-14) :-0.33
Mean Recommendation*:1.2
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback